Fresenius Medical Care Balboa II
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | $3.3m | Early VC | |
N/A | $2.8m | Early VC | |
N/A | $5.7m | Early VC | |
N/A | $2.6m | Early VC | |
* | N/A | $2.6m | Early VC |
N/A | $2.7m | Early VC | |
N/A | $2.9m | Early VC | |
* | N/A | $2.0m | Early VC |
N/A | $3.6m | Early VC | |
N/A | $1.1m | Early VC | |
N/A | $2.1m | Early VC | |
* | N/A | $2.0m Valuation: $13.5m | Late VC |
* | N/A | $3.6m | Early VC |
* | N/A | $3.4m | Late VC |
Total Funding | $40.2m |
Recent News about Fresenius Medical Care Balboa II
EditFresenius Medical Care North America (FMCNA) is the premier healthcare company focused on providing the highest quality care to people with renal and other chronic conditions. Through its industry-leading network of dialysis facilities and outpatient cardiac and vascular labs, Fresenius Medical Care North America provides coordinated healthcare services at pivotal care points for hundreds of thousands of chronically ill customers throughout the continent. As the world’s largest fully integrated renal company, it offers specialty pharmacy and laboratory services, and manufactures and distributes the most comprehensive line of dialysis equipment, disposable products, and renal pharmaceuticals. For more information, visit the FMCNA website at https://fmcna.com/.